Autoimmune disorders affect millions worldwide, occurring when the immune system mistakenly attacks healthy body tissues. Diagnosing conditions such as Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis, Sjogren's Syndrome, or Autoimmune Hepatitis requires precise laboratory evaluation.
Why ANA IFA is the Gold Standard#
- Superior Sensitivity: Anti-Nuclear Antibody (ANA) testing by Indirect Immunofluorescence Assay (IFA) on HEp-2 cells is recommended by international rheumatology guidelines over standard ELISA screening.
- Staining Pattern Analysis: ANA IFA identifies distinct cellular fluorescence patterns—Nuclear Homogeneous, Speckled, Nucleolar, Centromere, and Cytoplasmic—which pinpoint specific autoantibody candidates.
- Refinement via Immunoblotting: When an ANA IFA test returns positive, QXL Diagnostics conducts comprehensive ENA (Extractable Nuclear Antigen) profile panels to detect anti-dsDNA, anti-SS-A/Ro, anti-SS-B/La, anti-Sm, and anti-Scl-70 antibodies.
Early autoimmune screening prevents irreversible joint, kidney, and vascular damage.
Medical & Laboratory Disclaimer
This clinical article is published solely for patient education and informational purposes. It does not replace personal medical advice, clinical diagnosis, prenatal genetic counselling, or obstetric supervision. Appropriate laboratory investigations must be determined by your treating physician based on your personal health history.
Dr. Shantakumar Muruda, MD (Biochemistry)
Head of Clinical Biochemistry & Quality Management, QXL Diagnostics Bengaluru (NABL Accredited Laboratory MC-6849). Trained Lead Assessor for ISO 15189:2022 medical laboratory standards.
QXL Clinical Editorial Commitment: Every health guide, biomarker explanation, and screening schedule published on this portal undergoes rigorous clinical review by qualified MD pathologists and biochemists to ensure adherence to peer-reviewed evidence (ACOG, WHO, ICMR) and laboratory diagnostic accuracy.
